Chugoku Central Hospital

Hiroshima 7200001

0 studies enrolling now · 3 studies all time

What they study most

Follicular Lymphoma (FL), Lymphoma, Mantle-Cell, Lymphoma, Non-Hodgkin, Marginal Zone Lymphoma, Non Hodgkin Lymphoma

Studies at this site

• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling
• Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) — Stopped early
• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed